{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:59:43Z","timestamp":1777640383365,"version":"3.51.4"},"reference-count":26,"publisher":"Informa Healthcare","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1517\/13543776.2012.649006","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T12:17:44Z","timestamp":1324642664000},"page":"79-88","source":"Crossref","is-referenced-by-count":127,"title":["Novel therapies for glaucoma: a patent review 2007 \u2013 2011"],"prefix":"10.1517","volume":"22","author":[{"given":"Fabrizio","family":"Carta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Scozzafava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2011,12,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61423-7"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"Quigley HA","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"CIT0003","first-page":"243","volume-title":"Carbonic anhydrase \u2013 Its Inhibitors and Activators","author":"Mincione F","year":"2004"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/9780470508169.ch5"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9394(14)78354-0","volume":"32","author":"Friedenwald JS","year":"1949","journal-title":"Am J Ophthalmol"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archopht.1953.00920030409001","volume":"50","author":"Kinsey VE","year":"1953","journal-title":"Arch Ophthalmol"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9394(14)78372-2","volume":"32","author":"Kinsey VE","year":"1949","journal-title":"Am J Ophthalmol"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1951.tb00833.x"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9394(55)90022-2","volume":"39","author":"Becker B","year":"1955","journal-title":"Am J Ophthalmol"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1959.04220010082009"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.10.5.575"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2467"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.05.009"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.2174\/138161210793429797"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/med.10025"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.10.036"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.04.046"},{"key":"CIT0018","author":"Fabrizi F","year":"2011","journal-title":"J Enzyme Inhib Med Chem"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.bmcl.2009.03.111","volume":"19","author":"Chiroli V","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/1475636021000005659","volume":"17","author":"Loge C","year":"2002","journal-title":"J Enzyme Inhib Med Chem"},{"key":"CIT0059","first-page":"1171","volume":"119","author":"Honjo M","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1021\/jm100579r"},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/9780470508169.ch35","volume-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","author":"Finn P","year":"2009"},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/9780470508169.ch34","volume-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","author":"Schlitzer M","year":"2009"},{"key":"CIT0063","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/jop.2006.22.310","volume":"22","author":"Webb JG","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"CIT0064","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1021\/jm901226j","volume":"52","author":"Harrison BA","year":"2009","journal-title":"J Med Chem"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543776.2012.649006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T11:46:40Z","timestamp":1497959200000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543776.2012.649006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,4]]},"published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1517\/13543776.2012.649006"],"URL":"https:\/\/doi.org\/10.1517\/13543776.2012.649006","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,23]]}}}